AAAAAA

   
Results: 1-8 |
Results: 8
Recombinant lipoproteins: lipoprotein-like lipid particles for drug targeting
Authors: Rensen, PCN de Vrueh, RLA Kuiper, J Bijsterbosch, MK Biessen, EAL van Berkel, TJC
Citation: Pcn. Rensen et al., Recombinant lipoproteins: lipoprotein-like lipid particles for drug targeting, ADV DRUG DE, 47(2-3), 2001, pp. 251-276
Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice
Authors: Jong, MC Rensen, PCN Dahlmans, VEH van der Boom, H van Berkel, TJC Havekes, LM
Citation: Mc. Jong et al., Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice, J LIPID RES, 42(10), 2001, pp. 1578-1585
Determination of the upper size limit for uptake and processing of ligandsby the asialoglycoprotein receptor on hepatocytes in vitro and in vivo
Authors: Rensen, PCN Sliedregt, LAJM Ferns, A Kieviet, E van Rossenberg, SMW van Leeuwen, SH van Berkel, TJC Biessen, EAL
Citation: Pcn. Rensen et al., Determination of the upper size limit for uptake and processing of ligandsby the asialoglycoprotein receptor on hepatocytes in vitro and in vivo, J BIOL CHEM, 276(40), 2001, pp. 37577-37584
Apolipoprotein E protects against-bacterial lipopolysaccharide-induced lethality - A new therapeutic approach to treat Gram-negative sepsis
Authors: Van Oosten, MV Rensen, PCN Van Amersfoort, ES Van Eck, M Van Dam, AM Breve, JJP Vogel, T Panet, A Van Berkel, TJC Kuiper, J
Citation: Mv. Van Oosten et al., Apolipoprotein E protects against-bacterial lipopolysaccharide-induced lethality - A new therapeutic approach to treat Gram-negative sepsis, J BIOL CHEM, 276(12), 2001, pp. 8820-8824
Apolipoprotein E is resistant to intracellular degradation in vitro and invivo - Evidence for retroendocytosis
Authors: Rensen, PCN Jong, MC van Vark, LC van der Boom, H Hendriks, WL van Berkel, TJC Biessen, EAL Havekes, LM
Citation: Pcn. Rensen et al., Apolipoprotein E is resistant to intracellular degradation in vitro and invivo - Evidence for retroendocytosis, J BIOL CHEM, 275(12), 2000, pp. 8564-8571
Stable incorporation of a lipophilic daunorubicin prodrug into apolipoprotein E-exposing liposomes induces uptake of prodrug via low-density lipoprotein receptor in vivo
Authors: Versluis, AJ Rump, ET Rensen, PCN Van Berkel, TJC Bijsterbosch, MK
Citation: Aj. Versluis et al., Stable incorporation of a lipophilic daunorubicin prodrug into apolipoprotein E-exposing liposomes induces uptake of prodrug via low-density lipoprotein receptor in vivo, J PHARM EXP, 289(1), 1999, pp. 1-7
Design and synthesis of novel amphiphilic dendritic galactosides for selective targeting of liposomes to the hepatic asialoglycoprotein receptor
Authors: Sliedregt, LAJM Rensen, PCN Rump, ET van Santbrink, PJ Bijsterbosch, MK Valentijn, ARPM van der Marel, GA van Boom, JH van Berkel, TJC Biessen, EAL
Citation: Lajm. Sliedregt et al., Design and synthesis of novel amphiphilic dendritic galactosides for selective targeting of liposomes to the hepatic asialoglycoprotein receptor, J MED CHEM, 42(4), 1999, pp. 609-618
Low density lipoprotein receptor-mediated delivery of a lipophilic daunorubicin derivative to B16 tumours in mice using apolipoprotein E-enriched liposomes
Authors: Versluis, AJ Rensen, PCN Rump, ET Van Berkel, TJC Bijsterbosch, MK
Citation: Aj. Versluis et al., Low density lipoprotein receptor-mediated delivery of a lipophilic daunorubicin derivative to B16 tumours in mice using apolipoprotein E-enriched liposomes, BR J CANC, 78(12), 1998, pp. 1607-1614
Risultati: 1-8 |